Inactive

AMENDMENT NO. 1 - THE PURPOSE OF THIS AMENDMENT NO. 1 IS TO DELETE ATTACHMENT 1 PRODUCT DESCRIPTION AND REPLACE IT WITH THE REVISED ATTACHMENT 1 PRODUCT DESCRIPTION WHICH REMOVES REFERENCE TO INSTALLI... AMENDMENT NO. 1 - THE PURPOSE OF THIS AMENDMENT NO. 1 IS TO DELETE ATTACHMENT 1 PRODUCT DESCRIPTION AND REPLACE IT WITH THE REVISED ATTACHMENT 1 PRODUCT DESCRIPTION WHICH REMOVES REFERENCE TO INSTALLING THE EQUIPMENT. COMBINED SYNOPSIS / SOLICITATION (BRAND NAME ONLY) MOLECULAR DEVICES MULTICLAMP 700B AMPLIFIERS AND MOLECULAR DEVICES DIGIDATA 1550B4 DIGITIZERS FOR USE IN ELECTROPHYSIOLOGY EXPERIMENTS BRAND NAME ONLY (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95023Q00541_CSS and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2023-04, with effective date June 2, 2023. (iv) The associated NAICS code 334516 and the small business size standard is 1,000 employees. This requirement is full and open with no set-aside restrictions. (v) This requirement is for the following BRAND NAME ONLY equipment: Molecular Devices Multiclamp 700B w/one year warranty, Quantity 2 Molecular Devices Digidata 1550B4 w/one year warranty, including PClamp software, Quantity 2 (vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated delivery date is NLT six months after receipt of order (ARO). Delivery will be f.o.b. destination. The place of delivery and acceptance will be: Cellular Neurophysiology Section Building 35, 35 Convent Dr, Rm 3C-1002, Bethesda, MD 20814 (vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services (Mar 2023) FAR 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (Dec 2022) FAR 52.225-2, Buy American Certificate (Feb 2021) FAR 52.225-2, Buy American Certificate (Oct 2022) FAR 52.225-4, Buy American-Free Trade Agreements-Israel Trade Act Certificate (Dec 2022) 52.212-5 attachment, then also include Alternate I, II, or III (March 2023) FAR 52.225-6, Trade Agreements Certificate (Feb 2021) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services (Dec 2022). Addendum to this FAR clause applies to this acquisition and is attached. HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) FAR 52.212-4, Contract Terms and Conditions--Commercial Items (Dec 2022). Addendum to this FAR clause applies to this acquisition and is attached. HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders--Commercial Items (Mar 2023) NIH Invoice and Payment Provisions (viii) The Government will evaluate quotations or offers in accordance with FAR 13.106-2 and award a purchase order from this solicitation to the responsible offeror whose quote represents the lowest priced technically acceptable offer. (ix) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (Dec 2022), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (x) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Dec 2022), applies to this acquisition. Addendum to this FAR clause applies to this acquisition and is attached. (xi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. SUBMISSION INSTRUCTIONS (xii) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. Quote must include shipping and handling costs to provide single delivery of compounds to NINDS. ** Please provide two quotes if pricing varies based on foreign vs. domestic sourcing. Each quote must state whether the quote is a domestic and/or foreign quote. The Unique Entity ID from SAM.gov, UEI Number, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must submit a Buy American Certificate with their quote. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by 10:00 a.m., EST, on September 1, 2023, and reference Solicitation Number 75N95023Q00541_CSS. Responses must be submitted electronically to Valerie Whipple, Contracting Officer, at valerie.whipple@nih.gov. Fax responses will not be accepted. (xiii) The name and telephone number of the individual to contact for information regarding the solicitation: ATTACHMENTS Purchase Description FAR 52.212-4 Addendum FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes Executive Orders–Commercial Items (Mar 2023) FAR 52.225-2 Buy American Certificate (Oct 2022) NIH Invoice and Payment Instructions with IPP (April 2022)